Science Financial Statements From 2010 to 2025
| BEUT Stock | USD 0.0001 0.00 0.00% |
Check Science To financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Science To's main balance sheet or income statement drivers, such as , as well as many indicators such as . Science financial statements analysis is a perfect complement when working with Science To Valuation or Volatility modules.
Science |
Science to Consumers Company Shares Owned By Insiders Analysis
Science To's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Science To Shares Owned By Insiders | 65.78 % |
Most of Science To's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Science to Consumers is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 65% of Science to Consumers are shares owned by insiders. This is 367.52% higher than that of the Consumer Defensive sector and 281.55% higher than that of the Household & Personal Products industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Science to Consumers Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Science To's current stock value. Our valuation model uses many indicators to compare Science To value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Science To competition to find correlations between indicators driving Science To's intrinsic value. More Info.Science to Consumers is rated third in return on asset category among its peers. It is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Science To's earnings, one of the primary drivers of an investment's value.About Science To Financial Statements
Science To shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Science To investors may analyze each financial statement separately, they are all interrelated. The changes in Science To's assets and liabilities, for example, are also reflected in the revenues and expenses on on Science To's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name and distributing Argan oil products. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China. Science To is traded on OTC Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Science Pink Sheet Analysis
When running Science To's price analysis, check to measure Science To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science To is operating at the current time. Most of Science To's value examination focuses on studying past and present price action to predict the probability of Science To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science To's price. Additionally, you may evaluate how the addition of Science To to your portfolios can decrease your overall portfolio volatility.